Aytu BioScience Inc Acquires Prescription Product Portfolio from Cerecor Inc - M&A Call Transcript
Good afternoon, everyone, and thank you for joining us for this conference call discussing Aytu BioScience's announced acquisition of a six-product commercial portfolio. With me this afternoon to discuss the details of the acquisition is Aytu's Chairman and Chief Executive Officer, Josh Disbrow.
Aytu BioScience issued a press release this morning announcing the acquisition with details describing the transaction. A copy of the press release is available on the news page of the Company's website at aytubio.com.
I'd like to remind everyone that today's call is being recorded. A replay of today's call will be available by using the telephone numbers and conference ID provided in the press release. In addition, a webcast will be accessible live and archived on Aytu BioScience's website within the investors section under events and presentations at aytubio.com.
Finally, I'd also like to call your attention to the customary Safe Harbor disclosure regarding forward-looking information. The conference call today will contain certain forward-looking statements, including statements
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
